Maryland Prescription Drug Affordability Board

​Announcements

• UPCOMING MEETING: ​Prescription Drug Affordability Board Special Meeting​, Tuesday, June 30, 2026 at 9:00AM​. Meeting information can be found h​e​​​r​e.​​

• PROPOSED REGULATIONS: The Maryland Prescription Drug Affordability Board proposes to adopt new Regulations .01—.04 under a new chapter, COMAR 14.01.06 Implementation and Monitoring of Upper Payment Limits.  The text of the proposed regulations are available in the June 12, 2026 edition of the Maryland Register located here.​ For more information please visit the proposed regulations page of the PDAB website here. Comments will be accepted through July 13, 2026. ​

• PROPOSED REGULATIONS: The Maryland Prescription Drug Affordability Board proposes to adopt two new Regulations under a new Chapter COMAR 14.01.07 Upper Payment Limit:
   .01 Upper Payment Limit for Jardiance (empagliflozin); and
  .02 Upper Payment Limit for Ozempic (Semaglutide).
  The text of the proposed regulations are available in the June 26, 2026 edition of the Maryland Register located here. For more information please visit the proposed regulations page of the PDAB website here. Comments will be accepted through July 27, 2026. ​
  
  
  

• WRITTEN COMMENT REQUEST: Draft Proposed Regulations for Comment: The PDAB is soliciting comments on proposed revisions to COMAR 14.01.04 Cost Review Study Process.​​​ 
• Information can be found he​re.​

Join the PDAB Mailing List here​.​
​